Exclusive UniSafe distribution agreement between Owen Mumford and Nipro exceeds expectations in Japan with new biosimilar launch
The agreement has been in place since 2019 and has scored a major new product launch success in delivering a biosimilar product into the Japanese market. This biosimilar is used with cancer medicines.